Myelodysplastic Syndrome Market Insights Video

According to Cognitive Market Research, the global Myelodysplastic Syndrome market size was USD 3142.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 8.20% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 1257.00 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 942.75 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 722.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.
• Latin America had a market share of more than 5% of the global revenue with a market size of USD 157.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 62.85 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.
• The myelodysplastic syndrome with unilineage dysplasia category is the fastest growing segment of the Myelodysplastic Syndrome industry